Please login to the form below

Not currently logged in
Email:
Password:

icosapent ethyl

This page shows the latest icosapent ethyl news and features for those working in and with pharma, biotech and healthcare.

Amarin sues FDA over off-label policy

Amarin sues FDA over off-label policy

The lawsuit relates to the company's Vascepa (icosapent ethyl), an omega-3 fatty acid product that is used to reduce elevated levels of triglycerides in the blood.

Latest news

  • Teva launches first generic of GSK's Lovaza in US Teva launches first generic of GSK's Lovaza in US

    Teva said it believes it is the first company to file for approval of generic Lovaza (omega-3-acid ethyl esters capsules) and the first to secure marketing approval, which should ... Aside from GSK, the launch of a lower-priced Lovaza generic in the US

  • Amarin slides as FDA panel votes against fish oil therapy Amarin slides as FDA panel votes against fish oil therapy

    population. By a 9-2 margin, the panel said it would not support approval of the omega-3 fatty acid based Vascepa (icosapent ethyl) as a combination therapy with statin drugs ... One of the claims made by Amarin for Vascepa is that it reduces

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics